Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06974981 · ClinicalTrials.gov registry record

Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry

A clinical trial of Chronic Obstructive Pulmonary Disease and COPD, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.

Recruiting
Registry status
420
Enrollment target
1
Study location

NCT06974981 is a study of Chronic Obstructive Pulmonary Disease and COPD that is actively recruiting participants, run by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. The registered enrollment target is 420 participants, below the 1,749-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06974981, a study of Chronic Obstructive Pulmonary Disease and COPD, is actively recruiting participants, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.

RECRUITING
Registry status
420 participants
Enrollment target
1
Study location

Study Summary

The COPD in LCS Registry will identify and characterize individuals who have functional or radiographic evidence of COPD and are receiving lung cancer screening. Clinical information will be obtained from study participants including symptom burden, lung cancer risk, spirometry, imaging characteristics, and peripheral blood eosinophils.

Study Locations (1)

Pennsylvania

  • Thomas Jefferson University - Philadelphia

Trial Details

FieldValue
Enrollment Target 420 participants
Start Date 2025-01-02
Est. Completion 2027-12-30

What the Registry Record Tells You About NCT06974981

The ClinicalTrials.gov registry entry for NCT06974981 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,749-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (76% lower). The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 0 interventions.

NCT06974981 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06974981 about?

NCT06974981 is a clinical study titled "Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry". The COPD in LCS Registry will identify and characterize individuals who have functional or radiographic evidence of COPD and are receiving lung cancer screening. Clinical information will be obtained from study participants including symptom burden, lung cancer risk, spirometry, imaging characterist...

What is the current status of trial NCT06974981?

This trial is currently recruiting. The enrollment target is 420 participants. The study started on 2025-01-02. Estimated completion is 2027-12-30.

What conditions does trial NCT06974981 study?

This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease, COPD.

Who is sponsoring clinical trial NCT06974981?

This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06974981 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Obstructive Pulmonary Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.